---
title: "Nxera Receives $10 Mln Milestone Payment From AbbVie"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291283132.md"
description: "Nxera Pharma received a $10 million milestone payment from AbbVie for achieving the fourth R&D milestone in their neurological disease collaboration. This brings total payments to $40 million. Nxera remains eligible for up to $1.2 billion in additional milestones and royalties under the agreement established in 2022."
datetime: "2026-06-30T12:29:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291283132.md)
  - [en](https://longbridge.com/en/news/291283132.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291283132.md)
generator: "portal-rs"
---

# Nxera Receives $10 Mln Milestone Payment From AbbVie

Add  as your preferred news source on Google

 Add Now

Nxera Pharma Co., Ltd. (SOLTF) on Tuesday said it received a $10 million milestone payment from AbbVie (ABBV) after achieving a fourth R&D milestone under their multi-target drug discovery collaboration focused on neurological diseases.

The companies partnered in 2022 to discover GPCR-targeting medicines for neurological diseases using Nxera's NxWave platform. The milestone was triggered by the identification of validated and differentiated hit molecules against a neurology target.

With the latest payment, Nxera has received $40 million from AbbVie across four R&D milestones.

Under the agreement, Nxera is also eligible to receive potential option, development and commercial milestone payments totaling up to $1.2 billion, in addition to tiered royalties on global sales. 

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [4565.JP](https://longbridge.com/en/quote/4565.JP.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)

## Related News & Research

- [W1M Asset Management Ltd Acquires Shares of 5,460 AbbVie Inc. $ABBV](https://longbridge.com/en/news/297755003.md)
- [Canada Pension Plan Investment Board Buys Shares of 3,248,582 AbbVie Inc. $ABBV](https://longbridge.com/en/news/298099969.md)
- [AbbVie (NYSE:ABBV) Issues FY 2026 Earnings Guidance](https://longbridge.com/en/news/297966481.md)
- [AbbVie to Present at the Morgan Stanley 24th Annual Global Healthcare Conference | ABBV Stock News](https://longbridge.com/en/news/297911115.md)
- [First National Bank of Omaha Purchases 8,167 Shares of AbbVie Inc. $ABBV](https://longbridge.com/en/news/297396117.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**